Roper Industries, Inc. (identified in the request as Roper Technologies Inc.) — Q1 2012 Form 10-Q
Reporting period: Three months ended March 31, 2012; unaudited results compared with Q1 2011. The filing cautions that quarterly results are not necessarily indicative of full-year performance.
Business context
Roper described itself as a diversified manufacturer and provider of engineered products, software and services across Industrial Technology, Energy Systems & Controls, Medical & Scientific Imaging, and RF Technology. It acquired Shanghai Hao Ying Measurement & Control Technology and Cambridge Viscosity during the quarter; both were included in Energy Systems & Controls.
Financial performance
| Metric | Q1 2012 | Q1 2011 | Change |
|---|---|---|---|
| Net sales | $711.1 million | $645.3 million | +10.2% |
| Gross profit / margin | $391.2 million / 55.0% | $350.1 million / 54.3% | Margin +0.7 percentage points |
| Income from operations | $170.3 million | $142.0 million | +19.9% |
| Net earnings | $108.3 million | $89.0 million | +21.7% |
| Diluted EPS | $1.09 | $0.91 | +$0.18 |
| Operating cash flow | $141.5 million | $86.6 million | +63.4% |
Net sales growth comprised 8% organic growth, 3% from acquisitions and a 1% negative foreign-exchange impact. The effective tax rate was 29.8%, versus 29.4%. Interest expense declined to $15.5 million from $16.7 million. Dividends declared per share increased to $0.1375 from $0.1100.
Segments and material changes
- Industrial Technology sales rose 14.8% to $195.1 million; operating margin increased to 29.5% from 27.2%, supported by volume and operating leverage.
- Energy Systems & Controls sales rose 14.6% to $148.6 million; operating margin increased to 24.0% from 22.4%. Organic growth was 12%; acquisitions contributed about 3%.
- Medical & Scientific Imaging sales rose 12.1% to $162.8 million; operating margin increased to 26.6% from 24.1%, including a more favorable product mix.
- RF Technology sales rose 2.1% to $204.5 million; operating margin increased to 24.6% from 22.4%, partly reflecting lower comparative-period product development and intellectual-property costs.
Segment operating profit was $186.9 million before unallocated corporate expenses of $16.6 million; consolidated income from operations was $170.3 million. Net orders increased 4% to $729.4 million, while backlog was essentially unchanged at $850.6 million.
Cash flow, debt and liquidity
- Cash and cash equivalents were $451.7 million at March 31, up from $338.1 million at year-end. Operating activities provided $141.5 million; investing activities used $28.8 million, including $19.0 million for acquisitions and $10.0 million of capital expenditures; financing activities used $2.3 million.
- Total debt was $1.078 billion, compared with $1.085 billion at December 31; cash-adjusted net debt was $626.0 million, down from $746.9 million. Net debt to total net capital declined to 15.8% from 18.9%.
- No borrowings were outstanding on the revolving credit facility. The company reported compliance with its debt covenants and $54 million in outstanding letters of credit.
- $183 million of cash and short-term investments held by foreign subsidiaries was considered permanently reinvested; repatriation for domestic use would incur additional taxes. Management said cash generation and available borrowing capacity were expected to support U.S. operating requirements.
Outlook, risks and unusual items
No specific earnings or revenue guidance was provided. Management expected operating cash flows to support debt reduction, but said the pace would depend on acquisitions and existing-business performance. Capital expenditures for the rest of 2012 were expected to be comparable to prior years as a percentage of sales. The company maintained an active acquisition program but gave no estimate of future transactions.
- Risks cited include economic and geopolitical uncertainty, acquisition integration and liabilities, indebtedness, foreign exchange, interest rates, competition, cyclical markets, customer concentration, raw-material costs, product liability and warranties, government contracts, environmental matters, asbestos litigation, and potential impairment of substantial intangible assets.
- Ordinary-course litigation includes product-liability and employment claims; management believed provisions and insurance were adequate and did not expect a material adverse effect. The potential liability, if any, from asbestos claims could not be determined.
- A $500 million interest-rate swap converted the 6.625% 2013 senior notes to a variable-rate obligation at a 4.377% spread plus three-month LIBOR. Management estimated a 1 percentage-point rate increase would add about $5 million to annualized pretax interest cost.
- Foreign-currency translation increased net assets by $20.3 million in Q1; approximately $12.0 million related to goodwill and did not directly affect expected cash flows. The filing estimated that a 10% exchange-rate difference throughout the quarter would have affected net earnings by about $3.5 million.
- Convertible notes: conversions and a pending settlement involved cash payments; the filing said conversion at quarter-end could result in issuance of 1,077,835 shares. The notes’ conversion terms and potential dilution merit review.
Management reported effective disclosure controls and no material change in internal controls over financial reporting during the quarter. The filing also states that adoption of the accounting guidance described in Note 2 had no material effect on results, financial position or cash flows.
Investor verification priorities
- Reconcile organic growth, acquisition contributions and foreign-exchange effects, including the performance and purchase accounting of Hao Ying and Cambridge.
- Assess whether order intake and segment-level backlog support continued sales growth, particularly given the relatively flat total backlog.
- Review operating cash-flow sustainability, working-capital movements, and the company’s debt-reduction capacity alongside acquisition plans.
- Examine the 2013 debt maturity, variable-rate swap exposure, convertible-note settlement and potential share dilution.
- Evaluate foreign cash accessibility and tax costs, plus the uncertainty around asbestos and other contingent liabilities.